Elevated matrix metalloproteinase-9 and degradation of perineuronal nets in cerebrocortical multiple sclerosis plaques

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 9, 2008, Pages 888-899

  Gray, Elizabeth ^a   Thomas, Taya Louise ^a   Betmouni, Samar ^a   Scolding, Neil ^a   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cortical plaques; Extracellular matrix; Matrix metalloproteinase 9; Multiple sclerosis; Neurodegeneration; Parvalbumin; Perineuronal net

Indexed keywords

AGGLUTININ; GELATINASE B; NEUROFILAMENT PROTEIN; N ACETYLGLUCOSAMINE RECEPTOR; PARVALBUMIN; PLANT LECTIN; WISTERIA LECTIN;

ADULT; AGED; AGGLUTINATION TEST; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN REGION; CADAVER; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROFILAMENT; PERINEURIUM; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TISSUE SECTION; BIOSYNTHESIS; ENZYMOLOGY; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL CORTEX; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURONS; PARVALBUMINS; PLANT LECTINS; RECEPTORS, N-ACETYLGLUCOSAMINE;

EID: 52649093989     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318183d003     Document Type: Article

References (64)

1. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004;16:558-64
2. Celio MR, Blumcke I. Perineuronal nets-a specialized form of extracellular matrix in the adult nervous system. Brain Res Brain Res Rev 1994;19:128-45
3. Celio MR, Spreafico R, De Biasi S, Vitellaro-Zuccarello L. Perineuronal nets: Past and present. Trends Neurosci 1998;21:510-15
4. Fox K, Caterson B. Neuroscience. Freeing the brain from the perineuronal net. Science 2002;298:1187-89
5. Hockfield S, Kalb RG, Zaremba S, Fryer H. Expression of neural proteoglycans correlates with the acquisition of mature neuronal properties in the mammalian brain. Cold Spring Harb Symp Quant Biol 1990;55: 505-14
6. Lander C, Kind P, Maleski M, Hockfield S. A family of activity-dependent neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex. J Neurosci 1997;17:1928-39
7. Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002;298:1248-51
8. Bruckner G, Brauer K, Hartig W, et al. Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 1993;8:183-200
9. Bruckner G, Bringmann A, Koppe G, Hartig W, Brauer K. In vivo and in vitro labelling of perineuronal nets in rat brain. Brain Res 1996;720: 84-92
10. Bruckner G, Hartig W, Kacza J, Seeger J, Welt K, Brauer K. Extracellular matrix organization in various regions of rat brain grey matter. J Neurocytol 1996;25:333-46
11. Hartig W, Derouiche A, Welt K, et al. Cortical neurons immunoreactive for the potassium channel Kv3.1b subunit are predominantly surrounded by perineuronal nets presumed as a buffering system for cations. Brain Res 1999;842:15-29
12. Hartig W, Singer A, Grosche J, Brauer K, Ottersen OP, Bruckner G. Perineuronal nets in the rat medial nucleus of the trapezoid body surround neurons immunoreactive for various amino acids, calcium-binding proteins and the potassium channel subunit Kv3.1b. Brain Res 2001; 899:123-33
13. Hobohm C, Hartig W, Brauer K, Bruckner G. Low expression of extracellular matrix components in rat brain stem regions containing modulatory aminergic neurons. J Chem Neuroanat 1998;15:135-42
14. Bruckner G, Hausen D, Hartig W, Drlicek M, Arendt T, Brauer K. Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience 1999;92:791-805
15. Morawski M, Bruckner MK, Riederer P, Bruckner G, Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp Neurol 2004;188:309-15
16. Schuppel K, Brauer K, Hartig W, et al. Perineuronal nets of extracellular matrix around hippocampal interneurons resist destruction by activated microglia in trimethyltin-treated rats. Brain Res 2002;958:448-53
17. Bruckner G, Grosche J, Schmidt S, et al. Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R. J Comp Neurol 2000;428:616-29
18. Bukalo O, Schachner M, Dityatev A. Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 2001;104:359-69
19. Chiti Z, Knutsen OM, Betmouni S, Greene JR. An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease. Neurobiol Dis 2006;22: 363-73
20. Saghatelyan AK, Dityatev A, Schmidt S, Schuster T, Bartsch U, Schachner M. Reduced perisomatic inhibition, increased excitatory transmission, and impaired long-term potentiation in mice deficient for the extracellular matrix glycoprotein tenascin-R. Mol Cell Neurosci 2001; 17:226-40
21. Bruckner G, Seeger G, Brauer K, Hartig W, Kacza J, Bigl V. Cortical areas are revealed by distribution patterns of proteoglycan components and parvalbumin in the Mongolian gerbil and rat. Brain Res 1994;658: 67-86
22. Mulligan KA, van Brederode JF, Hendrickson AE. The lectin Vicia villosa labels a distinct subset of GABAergic cells in macaque visual cortex. Vis Neurosci 1989;2:63-72
23. Naegele JR, Arimatsu Y, Schwartz P, Barnstable CJ. Selective staining of a subset of GABAergic neurons in cat visual cortex by monoclonal antibody VC1.1. J Neurosci 1988;8:79-89
24. Nakagawa F, Schulte BA, Wu JY, Spicer SS. Postnatal appearance of glycoconjugate with terminal N-acetylgalactosamine on the surface of selected neurons in mouse brain. Dev Neurosci 1987;9:53-60
25. Hartig W, Brauer K, Bruckner G. Wisteria floribunda agglutininY labeled nets surround parvalbumin-containing neurons. Neuroreport 1992;3: 869-72
26. Kosaka T, Heizmann CW. Selective staining of a population of parvalbumin-containing GABAergic neurons in the rat cerebral cortex by lectins with specific affinity for terminal N-acetylgalactosamine. Brain Res 1989;483:158-63
27. Morino-Wannier P, Fujita SC, Jones EG. GABAergic neuronal populations in monkey primary auditory cortex defined by co-localized calcium binding proteins and surface antigens. Exp Brain Res 1992;88:422-32
28. Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri MM, Perry VH. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 1997;23:406-15
29. Cossins JA, Clements JM, Ford J, et al. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 1997;94:590-98
30. Maeda A, Sobel RA. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 1996;55:300-9
31. Lee MA, Palace J, Stabler G, Ford J, Gearing A, Miller K. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 1999;122:191-97
32. Leppert D, Ford J, Stabler G, et al. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 1998;121:2327-34
33. Waubant E, Goodkin DE, Gee L, et al. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 1999;53:1397-401
34. Yong VW, Zabad RK, Agrawal S, Goncalves Dasilva A, Metz LM. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 2007;59:79-84
35. Fainardi E, Castellazzi M, Bellini T, et al. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 2006;12:294-301
36. Gray E, Thomas TL, Betmouni S, Scolding N, Love S. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol 2008;18:86-95
37. Lichtinghagen R, Seifert T, Kracke A, Marckmann S, Wurster U, Heidenreich F. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis. J Neuroimmunol 1999;9:919-26
38. Lindberg RL, De Groot CJ, Montagne L, et al. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 2001;124:1743-53
39. Liuzzi GM, Trojano M, Fanelli M, et al. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Mult Scler 2002;8:222-28
40. Vos CM, van Haastert ES, de Groot CJ, van der Valk P, de Vries HE. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmunol 2003;138: 106-14
41. Waubant E, Goodkin D, Bostrom A, et al. IFNbeta lowers MMP-9/ TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology 2003;60:52-57
42. Asahina M, Yoshiyama Y, Hattori T. Expression of matrix metalloproteinase- 9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin Neuropathol 2001;20:60-63
43. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-b peptide (1-40). J Neurosci 1996;16: 7910-19
44. Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, Tokes ZA. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 1996;67:251-59
45. Lorenzl S, Albers DS, Narr S, Chirichigno J, Beal MF. Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease. Exp Neurol 2002;178:13-20
46. Baig S, Kehoe PG, Love S. MMP-2, -3 and -9 levels and activity are not related to Ab load in the frontal cortex in Alzheimer's disease. Neuropathol Appl Neurobiol 2008;34:205-15
47. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004;113: 1447-55
48. Jourquin J, Tremblay E, Decanis N, et al. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 2003;18:1507-17
49. Takeuchi H, Mizuno T, Zhang G, et al. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal
50. transport. J Biol Chem 2005;280:10444-54
51. Szklarczyk A, Lapinska J, Rylski M, McKay RD, Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 2002;22:920-30
52. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: Role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 2003;308:386-95
53. O'Connell JP, Willenbrock F, Docherty AJ, Eaton D, Murphy G. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem 1994;269:14967-73
54. Ogata Y, Itoh Y, Nagase H. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem 1995;270:18506-11
55. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-76
56. Muir EM, Adcock KH, Morgenstern DA, et al. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 2002;100:103-17
57. Rosenberg GA, Cunningham LA, Wallace J, et al. Immunohistochem-istry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 2001;893:104-12
58. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128:2705-12
59. Peterson JW, Bo L, MLrk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400
60. Peppin GJ, Weiss SJ. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci U S A 1986;83:4322-26
61. Gutowski NJ, Newcombe J, Cuzner ML. Tenascin-R and C in multiple sclerosis lesions: Relevance to extracellular matrix remodelling. Neuro-pathol Appl Neurobiol 1999;25:207-14
62. Klosen P, Anderton BH, Brion JP, van den Bosch de Aguilar P. Perikaryal neurofilament phosphorylation in axotomized and 6-OH-dopamine-lesioned CNS neurons. Brain Res 1990;526:259-69
63. Graeber MB, Lopez-Redondo F, Ikoma E, et al. The microglia/macro-phage response in the neonatal rat facial nucleus following axotomy. Brain Res 1998;813:241-53
64. Nakajima K, Graeber MB, Sonoda M, Tohyama Y, Kohsaka S, Kurihara T. In vitro proliferation of axotomized rat facial nucleus-derived activated microglia in an autocrine fashion. J Neurosci Res 2006;84:348-59